A Double Blinded, Placebo-Controlled Pilot Study to Examine Reduction of CD34+/CD117+/CD133+ Lymphoma Progenitor Cells and Duration of Remission Induced by Neoadjuvant Valspodar in Dogs With Large B-Cell Lymphoma

F1000Research - United Kingdom
doi 10.12688/f1000research.6055.2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Transformation of Double-Hit Large B-Cell Lymphoma Into B-Lymphoblastic Lymphoma: A Case Report

Journal of Hematopathology
Forensic MedicinePathologyHematologyHistology
2011English

Vitreoretinal Lymphoma Followed by Systemic Diffuse Large B Cell Lymphoma

Journal of Ophthalmic Inflammation and Infection
OphthalmologyInfectious Diseases
2019English

Spontaneous Regression of Intravascular Large B-Cell Lymphoma and Apoptosis of Lymphoma Cells: A Case Report

Journal of clinical and experimental hematopathology : JCEH
Medicine
2015English

Intravascular Large B-Cell Lymphoma

2020English

Diffuse Large B-Cell Lymphoma

2020English

Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study

Blood Cancer Journal
OncologyHematology
2016English

Steroid-Induced Lactic Acidosis in Diffuse Large B-Cell Lymphoma

Cureus
2020English

Follicular Lymphoma With Progression to Diffuse Large B-Cell Lymphoma and Concurrent CD5-Negative Mantle Cell Lymphoma-3 Entities in a Lymph Node

Cancer Control
MedicineOncologyHematology
2014English

Rituximab Maintenance for Patients With Diffuse Large B-Cell Lymphoma in First Complete Remission: Results From a Randomized Hovon-Nordic Lymphoma Group Phase Iii Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy